Pharming Group Nv Stock Investor Sentiment

PHGUF Stock  USD 0.75  0.07  8.54%   
Roughly 62% of Pharming Group's investor base is looking to short. The analysis of overall sentiment of trading Pharming Group NV pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Pharming Group's historical and current headlines, can help investors time the market. In addition, many technical investors use Pharming Group NV stock news signals to limit their universe of possible portfolio assets.
Pharming Group pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pharming daily returns and investor perception about the current price of Pharming Group NV as well as its diversification or hedging effects on your existing portfolios.
  
over a year ago at news.google.com         
Ischemia Reperfusion Injury Therapeutics Market Is Valued at USD ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Pharming Group to report second quarter and first half 2023 financial results on August 3 - Pharming...
Google News at Macroaxis
over a year ago at news.google.com         
With 6.0 percent CAGR, Hereditary Angioedema Treatment Market Growth ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Global Lactoferrin Market Size and Forecast Pharming Group NV ... - Reedley Exponent
Google News at Macroaxis
over a year ago at news.google.com         
Global Lactoferrin Market Size and Forecast Pharming Group NV ... - Reedley Exponent
Google News at Macroaxis
over a year ago at news.google.com         
Pharming announces sale of priority review voucher - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
GCC Countries Hereditary Angioedema Drug Industry Research ... - Scene for Dummies Everything Hollyw...
Google News at Macroaxis
over a year ago at news.google.com         
Lactoferrin Market players to make profitable investments during ... - Cottonwood Holladay Journal
Google News at Macroaxis
over a year ago at news.google.com         
Can Pharming Group N V ADS each representing 10 Ord Shs Stock Rise to the Top of Healthcare Sector F...
Google News at Macroaxis
over a year ago at news.google.com         
Is Pharming Group N V ADS each representing 10 Ord Shs Stock a Smart Investment Thursday - Investors...
Google News at Macroaxis
over a year ago at news.google.com         
Ischemia Reperfusion Injury Treatment Market is projected to grow at a CAGR of 6.1 percent from 2023...
Google News at Macroaxis
over a year ago at news.google.com         
Pharming N Notice of First Quarter 2023 Results - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Pharming announces the first commercial shipments of Joenja to patients in the U.S. - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Pharming wins FDA nod for immune disorder therapy NASDAQ ... - Seeking Alpha
Google News at Macroaxis
over a year ago at news.google.com         
Pharming Stock Reaps Significant Gains After Landmark FDA ... - Nasdaq
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pharming Group that are available to investors today. That information is available publicly through Pharming media outlets and privately through word of mouth or via Pharming internal channels. However, regardless of the origin, that massive amount of Pharming data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pharming Group news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pharming Group relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pharming Group's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pharming Group alpha.

Pharming Group Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pharming Pink Sheet analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments